1
/
of
1
McKesson
McKesson LiquiBand Flow Control Topical Skin Adhesive - 0.5mL Precision Applicator
McKesson LiquiBand Flow Control Topical Skin Adhesive - 0.5mL Precision Applicator
Regular price
$33.99 USD
Regular price
$42.99 USD
Sale price
$33.99 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
McKesson LiquiBand Flow Control Topical Skin Adhesive - Professional Medical Device
Important: This is a professional medical device intended for use by qualified healthcare professionals only. Please consult with appropriate medical personnel regarding proper application and suitability.
Product Overview:
Advanced professional-grade topical skin adhesive featuring n-butyl cyanoacrylate formulation with innovative flow control technology. Developed with input from clinicians worldwide for optimal performance in healthcare settings.
Technical Specifications:
- Volume: 0.5 mL (0.5g) per applicator
- Active ingredient: n-butyl cyanoacrylate
- Setting time: 30 seconds or less
- Application: Single layer application
- Storage: Ambient temperature storage
- Shelf life: Minimum 25-day guarantee
Innovative Design Features:
- Winged applicator: Ergonomic design for effortless activation and controlled expression
- Clear dome window: Visual monitoring of product volume for precise application control
- Precision tip: Allows for accurate placement and application
- Flow control technology: Smooth, controlled dispensing system
- Ready-to-use: No preparation required, immediate use from packaging
- Latex-free construction: Compatible with sensitive clinical environments
Professional Benefits:
- Microbial barrier protection: Protective barrier properties
- No removal required: Eliminates follow-up procedures
- Single layer application: Efficient procedure workflow
- Cosmetic outcomes: Designed for optimal aesthetic results
Professional Use Only: This medical device is intended for use by trained healthcare professionals in appropriate clinical settings. Proper training and facility protocols must be followed.
